GGrantIndex
← Leaderboards

Marc S Ernstoff

Dartmouth College

$5,989,395
Attributed
$7,670,666
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200520
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20

Funding mix

By agency

NIH$7,670,666 · 10

By mechanism

R01$2,261,484 · 1
U10$1,716,708 · 2
P30$1,702,017 · 3
UG1$1,071,295 · 1
R21$559,415 · 1
P20$359,747 · 2

Top collaborators

Most similar at Dartmouth College

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchClinical TrialsResearch PersonnelClinical DataLeadImmunotherapyClinical ProtocolsCancer Center Support GrantOperative Surgical ProceduresServicesBiometryMalignant NeoplasmsData ManagementCancer ImmunotherapyResource SharingResourcesLaboratoriesProgramsClinical Trials Cooperative GroupFeasibility StudiesDevicesGenomicsBioinformaticsClinical Investigator

Grant awards (32)

Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute$460,647
UG1 · FY2020 · CA
Clinical Protocol and Data Management$336,019
P30 · FY2020 · CA · contact PI
Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute$150,001
UG1 · FY2020 · CA
Protocol Review and Monitoring System$128,406
P30 · FY2020 · CA · contact PI
Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute$460,647
UG1 · FY2019 · CA
Clinical Protocol and Data Management$336,019
P30 · FY2019 · CA · contact PI
Protocol Review and Monitoring System$128,406
P30 · FY2019 · CA · contact PI
Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.$585,200
U10 · FY2018 · CA
Early Phase Clinical Research Support$185,526
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$6,057
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$5,342
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$4,790
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$3,213
P30 · FY2018 · CA · contact PI
Early Phase Clinical Research Support$1,667
P30 · FY2018 · CA · contact PI
Network Lead Academic Participating Site Grant from the Roswell Cancer Inst.$585,200
U10 · FY2017 · CA
Early Phase Clinical Research Support$188,105
P30 · FY2017 · CA · contact PI
Early Phase Clinical Research Support$2,814
P30 · FY2017 · CA · contact PI
Early Phase Clinical Research Support$189,017
P30 · FY2016 · CA · contact PI
Early Phase Clinical Research Support$186,636
P30 · FY2015 · CA · contact PI
Immunotherapy for Renal Cell Carcinoma$406,901
R01 · FY2010 · CA · contact PI
PERIPHERAL BLOOD MONONUCLEAR CELL (PBMC) GENE EXPRESSION IN METASTATIC RENAL CEL$239,831
P20 · FY2010 · RR · contact PI
Immunotherapy for Renal Cell Carcinoma$405,348
R01 · FY2009 · CA · contact PI
PERIPHERAL BLOOD MONONUCLEAR CELL (PBMC) GENE EXPRESSION IN METASTATIC RENAL CEL$119,916
P20 · FY2009 · RR · contact PI
Immunotherapy for Renal Cell Carcinoma$394,585
R01 · FY2008 · CA · contact PI
Lymphodepletion for Melanoma Patients$275,592
R21 · FY2007 · CA · contact PI
Lymphodepletion for Melanoma Patients$283,823
R21 · FY2006 · CA · contact PI
Immunotherapy for Renal Cell Carcinoma$351,550
R01 · FY2005 · CA
Immunotherapy for Renal Cell Carcinoma$351,550
R01 · FY2004 · CA
Immunotherapy for Renal Cell Carcinoma$351,550
R01 · FY2003 · CA
CANCER AND LEUKEMIA GROUP B (CALGB)$191,731
U10 · FY2002 · CA
CANCER AND LEUKEMIA GROUP B (CALGB)$183,262
U10 · FY2001 · CA
CANCER AND LEUKEMIA GROUP B (CALGB)$171,315
U10 · FY2000 · CA